Valuation: Alfresa Holdings Corporation

Market Cap 391B 2.41B 2.12B 1.95B 1.81B 3.42B 229B 3.49B 23.41B 9.07B 112B 9.04B 8.85B P/E 2026
11x
P/E 2027 * 16.6x
Enterprise Value 391B 2.41B 2.12B 1.95B 1.81B 3.42B 229B 3.49B 23.41B 9.07B 112B 9.04B 8.85B EV / Sales 2026
0.15x
EV / Sales 2027 * 0.12x
Free-Float
88.28%
Yield 2026
2.69%
Yield 2027 * 3.3%
06-21 Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100 CI
05-26 ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation CI
05-26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Nagashima Medical Instruments Co., Ltd. from Nagashima Holdings Co., Ltd. CI
05-18 Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2026, has closed with 6,307,800 shares, representing 3.47% for ¥14,999.95 million. CI
05-18 Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2026. CI
05-15 Alfresa Holdings Corporation authorizes a Buyback Plan. CI
05-15 Alfresa Holdings Corporation announces an Equity Buyback for 6,307,800 shares, representing 3.46% for ¥14,999.95 million. CI
05-15 Alfresa Holdings Corp - to buy back up to 3.5% of own shares worth about 15 billion yen RE
05-15 Alfresa Holdings Corporation Announces Cash Dividend for the Year-End of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026; Provides Cash Dividend Guidance for the Second Quarter-End and Year-End of the Fiscal Year Ending March 31, 2027 CI
05-15 Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and for the Fiscal Year Ending March 31, 2027 CI
04-07 Healios Secures 144 Million Yen Initial Order from Alfresa's Korean Unit for Cosmetic Raw Material MT
02-26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Techno Suzuta, Co.,Ltd. from Onsendo, K.K. CI
02-10 Alfresa Books 15.4 Billion Yen Gain from Sale Of Investment Securities MT
1 day+0.81%
1 week-0.12%
Current month-0.16%
1 month+0.16%
3 months-16.18%
6 months-11.75%
Current year-10.72%
1 week 2,144.5
Extreme 2144.5
2,211
1 month 2,144.5
Extreme 2144.5
2,242.5
Current year 2,106.5
Extreme 2106.5
2,685.5
1 year 1,968
Extreme 1968
2,685.5
3 years 1,897
Extreme 1897
2,685.5
5 years 1,505
Extreme 1505
2,685.5
10 years 1,505
Extreme 1505
3,350
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Tech/Sci/R&D Officer 63 2022-06-27
Corporate Officer/Principal 61 2020-03-31
Director TitleAgeSince
Director/Board Member 63 2007-05-31
Director/Board Member 65 2025-06-24
Director/Board Member 50 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%-0.12%+9.62%-0.30% 2.43B
+1.59%+1.87%-32.35%-15.45% 158B
+1.24%-1.16%-10.76%-10.10% 100B
+1.92%+1.39%-2.34%+49.88% 55.06B
-0.35%-1.24%+55.58%+49.06% 53.4B
+1.04%+3.47%-13.94%-42.09% 41.7B
+5.81%+15.76% - - 33.35B
+2.24%-1.28%-17.61%-46.42% 25.99B
+1.67%+7.22%+64.10%-4.57% 25.36B
+0.82%+2.48%-12.51%-5.64% 20.52B
Average +1.67%+2.73%+4.42%-2.85% 51.6B
Weighted average by Cap. +1.58%+1.92%-6.21%-2.65%

Financials

2026 2027 *
Net sales 3,099B 19.08B 16.75B 15.42B 14.37B 27.1B 1,814B 27.65B 185B 71.85B 890B 71.64B 70.09B 3,164B 19.48B 17.11B 15.75B 14.67B 27.67B 1,852B 28.23B 189B 73.38B 909B 73.16B 71.57B
Net income 37.04B 228M 200M 184M 172M 324M 21.68B 330M 2.22B 859M 10.64B 856M 838M 25.25B 155M 136M 126M 117M 221M 14.78B 225M 1.51B 585M 7.25B 584M 571M
Net Debt - -
Logo Alfresa Holdings Corporation
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Employees
12,452
Date Price Change Volume
26-07-01 JP¥2,170.50 +0.81% 168,600
26-07-01 JP¥2,153.00 -0.97% 428,000
26-06-30 JP¥2,174.00 -1.09% 620,600
26-06-29 JP¥2,198.00 +0.94% 511,600
26-06-26 JP¥2,177.50 +0.21% 362,600
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,153.00JPY
Average target price
2,500.00JPY
Spread / Average Target
+16.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2784 Stock